Home / Inspections / 1252348

FDA Inspection 1252348 — Merck Sharp & Dohme LLC

Merck Sharp & Dohme LLC — FEI 2510592

The FDA completed an inspection of Merck Sharp & Dohme LLC on December 12, 2024 in West Point, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 12, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
West Point, PA (United States)

Facility

Other inspections at this facility

  • 1229927 (VAI Fri Aug 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1155052 (VAI Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1103540 (VAI Fri Sep 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 938141 (VAI Fri Apr 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 895238 (VAI Fri Sep 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources